Quantum Blue TDM - Buhlmann Quantum Blue TDM Lateral Flow Assays

Quantum Blue TDM

Image

Quantum Blue® TDM
BÜHLMANN Quantum Blue®technology offers rapid and reliable applications for therapeutic drug monitoring (TDM) of anti-inflammatory biologics, thus providing powerful research tools for measuring ADL and IFX.

Shadow

Quantum Blue® TDM

The BUHLMANN Quantum Blue® Technology offers rapid and reliable applications for TDM. Quantum Blue® TDM assays are lateral flow immunoassays for the quantitative determination of trough levels of ADL and IFX in serum samples.

Quantum Blue® ADL, Anti-ADL Antibodies, IFX, and Anti-IFX Antibodies are for Research Use Only in the US. Not for use in diagnostic procedures.

Quantum Blue®ADL

The Quantum Blue®ADL assay measures from 1.3 to 35 µg/ml, and the target concentrations lies well within the linear range of the test. Quantum Blue® ADL is unique in the diagnostics market, being the first test that can provide fast, reliable information for ADL and it correlates well with the standard routine ELISAs for ADL level determinations.

Quantum Blue®Anti-ADL

The Quantum Blue® Anti-ADL Antibodies assay allows for a highly sensitive detection of antibodies against adalimumab within 15 min. This drug sensitive assay (measures non-antibody bound drug) combined with ease of use and a short incubation time offers a fast and reliable measurement of free anti-drug antibodies. Quantum Blue® ADL together with Quantum Blue® Anti-ADL Antibodies offers the complete solution for rapid testing on the popular Quantum Blue® platform.

Quantum Blue® IFX

The Quantum Blue® IFX assay measures from 0.4 to 20 µg/ml, and the target concentrations lies well within the linear range of the test. Quantum Blue® IFX provides a quantitative result within 15 minutes of incubation time. Quantum Blue® IFX is unique, being the only test that can provide fast, reliable information for IFX, and correlating well with the standard routine ELISAs for determination of IFX levels.

Quantum Blue® Anti-IFX Antibodies

The Quantum Blue® Anti-IFX Antibodies assay allows for a highly sensitive detection of antibodies against adalimumab within 15 min.  This drug sensitive assay (measures non-antibody bound drug) combined with ease of use and a short incubation time offers a fast and reliable measurement of free anti-drug antibodies. Quantum Blue® IFX, together with Quantum Blue® Anti-IFX Antibodies, offers the complete solution for rapid testing on the popular Quantum Blue® platform.